Man Group
PRCT icon

Man Group’s Procept Biorobotics PRCT Stock Holding History

Man Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.3M Buy
+291,832
New +$8.22M 0.01% 971
2025
Q3 		– Sell
-20,573
Closed -$1.19M – 2413
2025
Q2 		$1.19M Sell
20,573
-179,734
-90% -$10.2M ﹤0.01% 1581
2025
Q1 		$11.7M Sell
200,307
-55,445
-22% -$3.79M 0.03% 667
2024
Q4 		$20.6M Buy
255,752
+192,352
+303% +$16.4M 0.05% 417
2024
Q3 		$5.08M Buy
+63,400
New +$4.5M 0.01% 1020

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Man Group's PRCT Position: Q1 2026 in Review

Man Group opened a new position in Procept Biorobotics (PRCT) in Q1 2026: 291,832 shares worth $7.3M. The stake represents 0.01% of the portfolio and ranks #971 among its holdings. This is a return to the name: Man Group previously reported a position in PRCT as recently as Q2 2025.

Man Group first reported a position in PRCT in Q3 2024 and has held it in 5 quarters since. The position peaked at $20.6M in Q4 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Man Group held 291,832 shares of Procept Biorobotics worth $7.3M as of Q1 2026.
  • Procept Biorobotics was a new Man Group position in Q1 2026.
  • Procept Biorobotics made up 0.01% of Man Group's portfolio in Q1 2026, its #971 holding.
  • Man Group first reported a position in Procept Biorobotics in Q3 2024 and has held it in 5 quarters since.
  • Man Group's Procept Biorobotics position peaked at $20.6M in Q4 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.